Karyopharm Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Karyopharm Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Karyopharm Therapeutics Inc Strategy Report
- Understand Karyopharm Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Karyopharm Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 21 Dec 2021 | Menarini Enters into Licensing Agreement with Karyopharm Therapeutics | Licensing Agreement |
A. Menarini Industrie Farmaceutiche Riunite Srl
|
Karyopharm Therapeutics Inc |
| 26 Mar 2021 | Karyopharm Therapeutics Enters Manufacturing Agreement with MIAS Pharma for Nexpovio | Contract Service Agreement |
Karyopharm Therapeutics Inc
|
MIAS Pharma Ltd
|
| 11 Jan 2021 | Karyopharm Therapeutics Enters into Agreement with FORUS Therapeutics | Partnership | - |
Karyopharm Therapeutics Inc
FORUS Therapeutics Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer